Oral budesonide for prevention of postsurgical recurrence in Crohn's disease

Gastroenterology

Volumn 116, Issue 2, 1999, Pages 294-300

  Hellers, G ^a   Cortot, A ^a   Jewell, D ^a   Leijonmarck, C E ^a   Lofberg, R ^a   Malchow, H ^a   Nilsson, L G ^a   Pallone, F ^a   Pena, S ^a   Persson, T ^a   Prantera, C ^a   Rutgeerts, P ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; HYDROCORTISONE;

ACNE; ADULT; AGED; ANKLE EDEMA; ARTICLE; CLINICAL TRIAL; COLONOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN TEST; CROHN DISEASE; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HIRSUTISM; HUMAN; INTESTINE BIOPSY; INTESTINE SURGERY; MAJOR CLINICAL STUDY; MALE; MOON FACE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RECURRENT DISEASE; STEROID THERAPY;

EID: 0032900233     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(99)70125-3     Document Type: Article

References (23)

1. S Meyers DB. Sachar Medical management of Crohn's disease Hepatogastroenterology 37 1990 42 55
2. ME Stark WJ. Tremaine Maintenance of symptomatic remission in patients with Crohn's disease Mayo Clin Proc 68 1993 1183 1190
3. R. Brattsand Overview of newer glucocorticosteroid preparations for inflammatory bowel disease Can J Gastroenterol 4 1990 407 414
4. RN Brogden D. McTavish Budesonide An updated review of its pharmacological properties, and therapeutic efficacy in asthma and rhinitis Drugs 44 1992 375 407
5. P Rutgeerts R Löfberg H Malchow C Lamers G Olaison D Jewell O Ostergaard Thomsen H Lorenz-Meyer H Goebell H Hodgson T Persson C. Seidegard A comparison of budesonide with prednisolone for active Crohn's disease N Engl J Med 13 1994 842 845
6. GR Greenberg BG Feagan F Martin LR Sutherland ABR Thomson CN Williams LG Nilsson T Persson the Canadian inflammatory bowel disease study group Oral budesonide for active Crohn's disease N Engl J Med 13 1994 836 841
7. R Löfberg P Rutgeerts H Malchow C Lamers A Danielsson G Olaison D Jewell O Ostergaard Thomsen H Lorenz-Meyer H Goebell H Hodgson T Persson C. Seidegard Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study Gut 39 1996 82 86
8. G Greenberg B Feagan F Martin LR Sutherland ABR Thomson CN Williams LG Nilsson T Persson the Canadian inflammatory bowel disease study group Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled dose-ranging study Gastroenterology 110 1996 45 51
9. B Feagan GR Greenberg R Löfberg A Ferguson T. Persson Budesonide controlled ileal release prolongs remission in Crohn's disease: a pooled analysis Gastroenterology 112 suppl 4 1997 A970
10. G. Hellers Crohn's disease in Stockholm County 1955-79. A study of epidemiology, results of surgical treatment and long-term prognosis Acta Chir Scand 490 suppl 1979 1 84
11. P Rutgeerts K Geboes G Vantrappen R Kerremans JL Coene-grachts G. Coremans Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery Gut 25 1984 665 672
12. P Rutgeerts K Geboes G Vantrappen J Beyls R Kerremans M. Hiele Predictability of the postoperative course of Crohn's disease Gastroenterology 99 1990 956 963
13. S Edsbäcker P Wollmer Å Nilsson Pharmacokinetics and gastrointestinal transit of budesonide controlled ileal release (CIR) capsules (abstr) Gastroenterology 104 1993 A695
14. J. Lennard-Jones Classification of inflammatory bowel disease Scand J Gastroent 24 suppl 170 1989 2 6
15. WR Best JM Becktel JW Singleton F Kern Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's disease study Gastroenterology 70 1976 439 444
16. CH Florent A Cortot P Quandale T Sahmound R Modigliani E Sarfaty P Valleur JL Dupas M Daurat JL Faucheron E Lerebours F Michot J Belaiche N Jacquet JC Soule N Rothman JP Gendre M. Malafosse Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives (GETAID) Eur J Gastroenterol Hepatol 8 1996 229 233
17. R Fiasse F Fontaine R. Vanheuverzwyn Prevention of Crohn's disease recurrence after intestinal resection with Eudragid-Lcoated 5-aminosalicylic acid. Preliminary results of a one-year double-blind placebo-controlled study (abstr) Gastroenterology 100 1991 A208
18. LR Sutherland F Martin RJ Bailey RN Fedorak M Poleski C Dallaire R Rossman F Saibil L. Lariviere A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease Gastroenterology 112 1997 1069 1077
19. H Lochs M Mayer WE Fleig PB Mortensen P. Bauer Prophylaxis of postoperative relapse in Crohn's disease with mesalazine (Pentasa) in comparison to placebo Gastroenterology 112 4Suppl 1997 A1027
20. RS McLeod BG Wolff AH Steinhart PW Carryer K O'Rourke DF Andrews JE Blair JR Cangemi Z Cohen JB. Cullen Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease Gastroenterology 109 1995 404 413
21. C Brignola M Cottone A Pera S Ardizzone ML Scribano R De Franchis A D'Arienzo G D'Albasio D. Pennestri Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease Gastroenterology 108 1995 345 349
22. MA. Peppercorn Should all Crohn's disease patients receive prophylactic medication after surgical resection? No Inflam Bowel Dis 1 1995 162 164
23. P Rutgeerts M Hiele K Geboes M Peeters F Penninckx R Aerts R. Kerremans Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection Gastroenterology 108 1995 1617 1621